Audere receives fda emergency use authorization for healthpulse@home covid-19 specimen collection test kit

Seattle--(business wire)-- #covid19--audere, a digital health nonprofit developing solutions to improve global health, announced that it has received an emergency use authorization (eua) for healthpulse@home from the u.s. food and drug administration (fda).1 using the solution's authorized labeling instructions, healthpulse@home seamlessly allows clia-certified laboratories to bring their own self-collection covid-19 specimen kits to market without needing to obtain their own fda eua. healthpulse@home pro
LMDX Ratings Summary
LMDX Quant Ranking